Andere Sprachen Physiomics Plc

Aktien

Markt geschlossen - London S.E. Andere Börsenplätze 17:35:00 28.06.2024			% 5 Tage	% 1. Jan.
1,2 ^GBX	0,00 %		-4,00 %	-25,00 %

14.06.	Physiomics Plc erweitert DoseMe's Plattform für Präzisionsdosierung um Modellierungs- und Data Science-Funktionalität	CI
13.06.	Physiomics sichert sich Vertrag für virtuelle Tumorplattform	MT

EARNINGS AND TRADING: Sound Energy sells part of Moroccan assets	14.06.
Physiomics Plc Adds Modeling and Data Science Functionality to DoseMe's Precision Dosing Platform	14.06.
Physiomics Secures Virtual Tumor Platform Contract	13.06.
Physiomics inks contract with old client worth GBP186,000	13.06.
Physiomics plc Wins New Contract by Existing, Large Client	13.06.
Physiomics wins "significant" GBP160,000 contract	07.06.
Physiomics Secures Virtual Tumor Technology Deal With UK Biotech Company	07.06.
Physiomics plc Wins Significant Contract by A New UK-Based Biotech Client	07.06.
EXECUTIVE CHANGES: Pendragon chair to remain chair of Pinewood Tech	01.06.
Physiomics Chief Scientist Steps Down	31.05.
Dr. Christophe Chassagnole Step Down as Director and as Chief Scientific Officer of Physiomics plc	31.05.
Physiomics warns large contracts taken longer than expected	03.05.
AIM WINNERS & LOSERS: Fletcher King optimistic; Angle in Astra deal	03.05.
Physiomics Plc Increases Revenue Expectation for the Year 2025	03.05.
Physiomics Plc Provides Earnings Guidance for the Financial Year Ending 30 June 2024	03.05.
Physiomics celebrates "substantial" contract with old client	18.03.
Physiomics Wins DNA-related Modeling Contract with Large Pharmaceutical Company	18.03.
Physiomics plc Wins Contract by an Existing Pharma Client	18.03.
Physiomics reports higher interim revenue; loss narrows	07.03.
Physiomics Plc Reports Earnings Results for the Half Year Ended December 31, 2023	07.03.

Keine Ergebnisse zu dieser Suche